Immunome Inc (IMNM) — Capital Reinvestment Ratio

Latest as of March 2023: 0.00x

Immunome Inc (IMNM) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($24.17 Million) in capital expenditures ($106.00K). See IMNM net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$24.17 Million

USD

Capital Expenditures

$106.00K

USD

Data as of

Mar 2023

Most recent filing

Annual Capital Reinvestment Ratio for Immunome Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Immunome Inc from None to None. For live market cap and broader valuation context, see Immunome Inc (IMNM) market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow